Price
Financials
Standalone, Rs crore| Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.56 | 0.09 | 0.00 | 0.24 | 0.00 | 0.14 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 2.76 | 0.30 | 6.04 | 0.34 | 0.14 | 0.30 | 30.29 | 0.00 | 0.11 | -0.34 | 0.12 | 0.06 |
| Operating Profit | -0.20 | -0.21 | -6.04 | -0.10 | -0.14 | -0.16 | -30.24 | 0.00 | -0.11 | 0.34 | -0.12 | -0.06 |
| OPM % | -7.81% | -233.33% | -41.67% | -114.29% | -60,480.00% | |||||||
| Other Income | 0.27 | 0.27 | 0.38 | 0.00 | 0.02 | 0.11 | 0.69 | 0.00 | 0.00 | 0.00 | 0.93 | 0.00 |
| Interest | 0.00 | 0.00 | 0.18 | 0.00 | 0.00 | 0.00 | -0.07 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 |
| Depreciation | 0.62 | 0.62 | 0.27 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | 0.03 | 0.01 | 0.01 | 0.01 |
| Profit before tax | -0.55 | -0.56 | -6.11 | -0.10 | -0.12 | -0.05 | -29.53 | 0.00 | -0.14 | 0.33 | 0.74 | -0.07 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | -0.55 | -0.56 | -6.11 | -0.10 | -0.12 | -0.05 | -29.53 | 0.00 | -0.14 | 0.33 | 0.73 | -0.07 |
| EPS in Rs | -0.06 | -0.06 | -0.62 | -0.01 | -0.01 | -0.01 | -2.99 | 0.00 | -0.01 | 0.03 | 0.07 | -0.01 |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Jun 2011 15m | Jun 2012 | Jun 2013 9m | Mar 2014 | Mar 2015 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 112.71 | 107.88 | 119.41 | 188.39 | 202.75 | 147.74 | 38.91 | 23.96 | 2.62 | 0.42 | 0.00 |
| Expenses | 88.58 | 100.23 | 107.70 | 203.12 | 189.89 | 214.97 | 50.99 | 82.59 | 9.08 | 8.32 | -0.05 |
| Operating Profit | 24.13 | 7.65 | 11.71 | -14.73 | 12.86 | -67.23 | -12.08 | -58.63 | -6.46 | -7.90 | 0.05 |
| OPM % | 21.41% | 7.09% | 9.81% | -7.82% | 6.34% | -45.51% | -31.05% | -244.70% | -246.56% | -1,880.95% | |
| Other Income | 1.08 | 1.83 | 2.67 | 1.62 | 9.07 | 2.81 | 7.64 | 1.47 | 0.93 | -19.79 | 0.93 |
| Interest | 3.62 | 5.18 | 7.57 | 9.99 | 9.09 | 15.22 | 1.90 | 0.08 | 0.18 | 0.01 | 0.06 |
| Depreciation | 1.26 | 1.62 | 1.83 | 2.12 | 2.33 | 3.20 | 2.76 | 2.77 | 1.51 | 0.05 | 0.06 |
| Profit before tax | 20.33 | 2.68 | 4.98 | -25.22 | 10.51 | -82.84 | -9.10 | -60.01 | -7.22 | -27.75 | 0.86 |
| Tax % | 34.19% | 59.70% | 22.09% | -31.09% | 29.12% | 0.65% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | 13.38 | 1.08 | 3.88 | -17.38 | 7.45 | -83.38 | -9.09 | -60.01 | -7.22 | -27.76 | 0.85 |
| EPS in Rs | 3.47 | 0.21 | 0.74 | -3.31 | 1.42 | -8.45 | -0.92 | -6.08 | -0.73 | -2.81 | 0.08 |
| Dividend Payout % | 8.65% | 48.61% | 13.53% | -1.21% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | -71% | -86% | -100% | ||
| Compounded Profit Growth | % | % | 24% | 103% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | % | % | % | % |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Mar 2014 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.72 | 10.50 | 10.50 | 10.50 | 52.50 | 98.66 | 98.66 | 98.66 | 98.66 | 98.66 |
| Reserves | 39.34 | 73.69 | 76.96 | 61.00 | 26.44 | -56.94 | -66.03 | -126.04 | -133.26 | -161.02 |
| Borrowings | 32.75 | 47.89 | 56.67 | 51.62 | 53.70 | 96.15 | 89.05 | 88.76 | 85.71 | 65.45 |
| Other Liabilities | 39.81 | 44.35 | 57.50 | 65.66 | 89.66 | 55.67 | 30.87 | 25.48 | 24.50 | 22.41 |
| Total Liabilities | 119.62 | 176.43 | 201.63 | 188.78 | 222.30 | 193.54 | 152.55 | 86.86 | 75.61 | 25.50 |
| Fixed Assets | 27.56 | 31.68 | 35.95 | 36.53 | 37.04 | 38.78 | 35.58 | 33.08 | 31.57 | 0.20 |
| CWIP | 1.22 | 0.57 | 2.27 | 1.26 | 0.14 | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 |
| Investments | 1.52 | 0.78 | 0.89 | 2.90 | 4.80 | 4.69 | 4.69 | 4.59 | 4.59 | 0.00 |
| Other Assets | 89.32 | 143.40 | 162.52 | 148.09 | 180.32 | 150.03 | 112.24 | 49.15 | 39.45 | 25.30 |
| Total Assets | 119.62 | 176.43 | 201.63 | 188.78 | 222.30 | 193.54 | 152.55 | 86.86 | 75.61 | 25.50 |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Mar 2014 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -17.59 | -41.00 | 4.58 | 20.73 | 11.90 | -56.67 | 9.59 | -28.64 | -0.92 | -16.08 |
| Cash from Investing Activity | -9.00 | -3.24 | -6.58 | -2.60 | -1.29 | -1.10 | 2.28 | 1.11 | 0.96 | 16.13 |
| Cash from Financing Activity | 27.23 | 45.84 | 1.87 | -15.32 | -8.97 | 73.97 | -9.01 | -0.34 | 0.00 | 0.00 |
| Net Cash Flow | 0.64 | 1.60 | -0.13 | 2.81 | 1.64 | 16.20 | 2.86 | -27.87 | 0.04 | 0.05 |
| Free Cash Flow | -24.83 | -46.04 | -3.23 | 18.49 | 9.98 | -61.78 | 9.88 | -28.63 | -0.87 | -5.42 |
| CFO/OP | -56% | -496% | 48% | -144% | 94% | 84% | -81% | 51% | 14% | 204% |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Mar 2014 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 63.67 | 58.46 | 89.01 | 34.31 | 74.58 | 73.47 | 186.21 | 118.67 | 1,159.08 | 321.55 |
| Inventory Days | 205.43 | 260.28 | 262.28 | 105.11 | 146.58 | 23.77 | 39.69 | 17.12 | 153.76 | 929.88 |
| Days Payable | 132.88 | 130.68 | 189.09 | 124.09 | 160.85 | 89.83 | 266.31 | 350.12 | 3,211.71 | 17,598.21 |
| Cash Conversion Cycle | 136.22 | 188.06 | 162.20 | 15.34 | 60.32 | 7.42 | -40.42 | -214.33 | -1,898.87 | -16,346.79 |
| Working Capital Days | 158.78 | 331.23 | 319.39 | 138.01 | 145.03 | 169.97 | 498.20 | 358.75 | 2,061.83 | 2,355.12 |
| ROCE % | 7.34% | 9.09% | -11.37% | 15.48% | -49.65% | -5.31% | -65.43% | -8.16% | -26.09% |
Fundamentals
Market Cap₹ Cr.
Current Price₹ 0.48
Book Value₹ -6.23
ROCE-26.1 %
ROE%
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-100%
Compounded Profit Growth (TTM)103%
Standalone figures.
Valuation
P/B, 3-year average-0.16x
P/B, 5-year average0.16x
Profitability
Operating margin (excl. other income)-1880.95%
Operating margin (incl. other income)-6592.86%
EBITDA margin221.43%
Pre-tax margin204.76%
Net profit margin202.38%
ROE57.26%
ROCE-102.36%
ROA-54.91%
ROE, 3-year average-735.18%
ROCE, 3-year average-60.12%
ROA, 3-year average-37.98%
ROE, 5-year average-473.64%
ROCE, 5-year average-47.18%
ROA, 5-year average-31.86%
ROIC (approx.)29.90%
Other income / net worth31.74%
Growth
Sales growth (latest year)-83.97%
Sales CAGR, 3 years-77.90%
Sales CAGR, 5 years-70.94%
Profit growth QoQ-109.59%
Per share
EPS (TTM)Rs 0.09
EPS (latest year)Rs -2.81
EPS (latest quarter)Rs -0.01
EPS, 3-year averageRs -3.21
EPS, 5-year averageRs -3.80
Book value per shareRs -6.32
Sales per shareRs 0.04
Cash flow per shareRs -1.63
Free cash flow per shareRs -0.55
Efficiency
Asset turnover0.02x
Fixed asset turnover2.10x
Inventory turnover0.40x
Inventory days908 days
Debtor days322 days
Debtors turnover1.14x
Creditor days17598 days
Cash conversion cycle-16347 days
Working capital days2355 days
Leverage
Total debtRs 65 Cr
Cash and bankRs 0 Cr
Net debtRs 65 Cr
Debt to equity-1.05x
Net debt / EBITDA70.18x
Interest coverage87.00x
Owners' fund to total sources-244.55%
Debt to assets256.67%
Cash flow
Cash from Operating Activity (latest year)Rs -16 Cr
Cash from Investing Activity (latest year)Rs 16 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs -5 Cr
FCFE (approx.: FCF + change in debt)Rs -26 Cr
Statement figures
Net sales (TTM)Rs 0 Cr
Net sales (latest year)Rs 0 Cr
Operating profit excl. other income (latest year)Rs -8 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs -20 Cr
EBITDA (TTM)Rs 1 Cr
PBDT (TTM)Rs 1 Cr
Profit before tax (TTM)Rs 1 Cr
Net profit (TTM)Rs 1 Cr
Net profit (latest year)Rs -28 Cr
Net profit (latest quarter)Rs -0 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total expenditure (latest year)Rs 8 Cr
Total income (latest year)Rs -19 Cr
Share capitalRs 99 Cr
ReservesRs -161 Cr
Shareholders' fundsRs -62 Cr
Total assetsRs 26 Cr
Net blockRs 0 Cr
ReceivablesRs 0 Cr
InventoryRs 1 Cr
Other liabilitiesRs 22 Cr
Shares outstanding (crore)9.87
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
F-score 2 of 8| serious | Negative equity Shareholders' equity is negative |
| look | Inventory outrunning sales Inventory grew 0% vs sales -84% in 2015 |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2016Sales ₹0 Cr.
Net loss ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Hiran Orgochem Ltd?
Hiran Orgochem Ltd (506170) has a market capitalisation of Rs Cr. at the close.
What were Hiran Orgochem Ltd's latest quarterly results?
In the Jun 2016 quarter, Hiran Orgochem Ltd sales was Rs 0 Cr with a net loss of Rs 0 Cr.